Early Treatment Diabetic Retinopathy Study Research Group

C peptide and the classification of diabetes mellitus patients in the early treatment diabetic retinopathy study.
Early treatment diabetic retinopathy study research group. Etdrs report number 9. Baseline cohort characteristics from the early treatment diabetic retinopathy study etdrs suggest that a substantial percentage of eyes with central involved. Prior mj prout t miller d ewart r kumar d early treatment diabetic retinopathy research group. Data from the early treatment diabetic retinopathy study etdrs show that focal photocoagulation of clinically significant diabetic macular edema substantially reduces the risk of visual loss.
The early treatment diabetic retinopathy study etdrs a multicenter collaborative clinical trial supported by the national eye institute was designed to assess whether argon laser photocoagulation or aspirin treatment can reduce the risk of visual loss or slow the progression of diabetic retinopathy in patients with mild to severe nonproliferative or early proliferative diabetic retinopathy. One eye of each patient was assigned randomly to early photocoagulation and the other to deferral of photocoagulation. No authors listed the early treatment diabetic retinopathy study etdrs enrolled 3711 patients with mild to severe nonproliferative or early proliferative diabetic retinopathy in both eyes. A study to learn more about the eye intraocular pressure ocular hemodynamics after intravitreal injections rochester mn.
Prior mj prout t miller d ewart r kumar d. The early treatment diabetic retinopathy study research group. Early treatment diabetic retinopathy study research group. In the early treatment diabetic retinopathy study a randomized clinical trial sponsored by the national eye institute one eye of each patient was assigned to early photocoagulation and the other.